EP2830626
FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.3.2013EP published:
2.1.2019EP application number:
13712589.4
EPO information:
European Patent Register
Max expiry date:
28.3.2033
Title:
FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS
Timeline
Today
29.3.2013EP application
2.1.2019EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
KNEISSEL, MichaelaAddress:
Basel, CH
Name:
GUAGNANO, VitoAddress:
Basel, CH
Name:
GRAUS PORTA, DianaAddress:
Basel, CH
Name:
WÖHRLE, SimonAddress:
Freiburg, DE
Priority
Number:
201261617889 PDate:
30.3.2012Country:
US
Classification
Categories:
A61P 3/12, A61P 19/08, A61K 38/17, A61K 38/29, A61K 45/06, A61K 31/59, A61K 33/06, A61K 33/42, A61K 31/506